January 31, 2012 — UAS Laboratories Inc. has announced the introduction of a new probiotic product. The product, DDS Plus 3, is based upon the formula, Probioplus DDS.
The product contains four probiotic strains including the extensively researched Lactobacillus acidophilus DDS-1. UAS Laboratories is the owner of the trademark for L. acidophilus DDS-1. The other probiotics in the new product include: Bifidobacterium longum, Bifidobacterium bifidum, and Bifidobacterium lactis.
Like all DDS Probiotics, DDS Plus 3 also contains the prebiotic, fructooligosaccharide (FOS), that ensures the probiotics optimize their colonization in the GI tract. DDS Plus 3 will be offered at a maintenance level of 6 billion CFU/gram (Probioplus DDS has 10 billion CFU/gram) and is positioned to be the most cost-effective premium probiotic in its class.
Source: UAS Laboratories Inc., uaslabs.com
Related Posts
Spondylolisthesis treatment: epidemiology, vertebral subluxation and children- Parker University president to present Annual Joseph Janse Lecture
- Topical vs. oral NSAIDs for joint and arthritis pain
- Sherman College of Chiropractic honors 2 chiropractors
- Performance Health to present at 59th annual ACSM meeting
- Over 1,700 athletes compete in Foot Levelers Blue Ridge Marathon
